Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience. (Q51013117)
Jump to navigation
Jump to search
scientific article published in September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience. |
scientific article published in September 2011 |
Statements
1 reference
Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience. (English)
1 reference
Jun Horiguchi
1 reference
Tetsunari Oyama
1 reference
Daisuke Takata
1 reference
Nana Rokutanda
1 reference
Rin Nagaoka
1 reference
Hiroki Odawara
1 reference
Hideaki Tokiniwa
1 reference
Katsunori Tozuka
1 reference
Mami Kikuchi
1 reference
Ayako Sato
1 reference
Izumi Takeyoshi
1 reference
1 September 2011
1 reference
1 reference
31
1 reference
9
1 reference
3041-3046
1 reference
Identifiers
1 reference